Previous studies proposed that tumor cells with mutant TP53 possess high expression of PD‐L1 at both the mRNA and protein levels, which could suppress the cytotoxic effects of T cells and protect tumors from effector‐immune responses.[71, 72, 73] For instance, Liu et al. Here, TP53 is linked to neoplasm.